Achaogen Inc. | Mutual Funds
Mutual Funds that own Achaogen Inc.
SPDR S&P Biotech ETF
2,980,609
6.59%
7,776
0.27%
09/06/2018
Vanguard Total Stock Market Index Fund
887,676
1.96%
71,800
0%
07/31/2018
Fidelity Small Cap Growth Fund
718,195
1.59%
190,255
0.08%
04/30/2018
AXA Framlington Biotech Fund
615,139
1.36%
535,460
0.46%
02/28/2018
iShares Russell 2000 ETF
608,031
1.35%
-324
0.01%
09/06/2018
iShares Nasdaq Biotechnology ETF
516,563
1.13%
-6,762
0.03%
09/06/2018
Vanguard Extended Market Index Fund
430,611
0.95%
-382
0%
07/31/2018
iShares Russell 2000 Growth ETF
310,501
0.69%
0
0.01%
09/06/2018
Managers AMG TimesSquare Small Cap Growth Fund
215,600
0.48%
-9,400
0.08%
06/29/2018
Fidelity Spartan Extended Market Index Fund
155,533
0.34%
0
0%
07/31/2018
| Address |
1 Tower Place
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.achaogen.com |
| Updated |
09/14/2018 |
| Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E. |
